AB 228 requires California public school districts, county offices of education, and charter schools to stock at least one FDA‑approved epinephrine delivery device on campus and to make it accessible to school nurses or trained volunteers for emergency use. The measure defines key terms, establishes training and notification duties, prescribes minimum quantities per school level, and sets rules for restocking and storage.
The bill matters to school administrators, school health staff, risk managers, and suppliers because it converts an emergency best practice into a statutory obligation with specific operational tasks: prescription procurement, annual notice and volunteer recruitment, recurring training standards, a two‑week restocking deadline after use, and indemnification for volunteers and nurses. It also permits private schools to opt out and allows acceptance of donations from manufacturers or other sources.
At a Glance
What It Does
Requires public K–12 schools to maintain FDA‑approved epinephrine delivery systems on campus, assign them to nurses or trained volunteers, and follow state‑defined training, storage, and restocking rules. It also authorizes private schools to decline participation.
Who It Affects
Public school districts, county offices of education, charter schools, school nurses, employees who volunteer for medication administration, school administrators responsible for prescriptions and inventory, and suppliers or donors of epinephrine devices.
Why It Matters
The bill converts informal emergency practice into concrete operational obligations—quantities, timelines, training content, liability protections, and procurement channels—which create compliance, budgetary, and supply‑chain considerations for education and health officers.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
AB 228 directs public school systems to keep at least one FDA‑approved epinephrine delivery system (an auto‑injector style disposable device) accessible on campus and assigned to school nurses or employees who volunteer and complete approved training. The device may be used on anyone at the school who is suffering, or reasonably believed to be suffering, from anaphylaxis; the law clarifies what anaphylaxis looks like and lists common triggers.
The measure sets a prescription model: a qualified health supervisor must obtain an authorizing physician’s prescription for each school and handle stocking and restocking duties. It specifies minimum quantities by school level (detailed below), allows prescriptions to be filled by local or mail‑order pharmacies or directly by manufacturers, and requires used devices to be replaced no later than two weeks after use and replenished prior to expiration.Training is mandatory for volunteers and must follow standards the State Superintendent reviews at least every five years.
Those standards must align with federal voluntary CDC guidance and cover symptom recognition, storage and restocking procedures, emergency follow‑up (including calling 911 and contacting parents and physicians), CPR recommendations, and guidance on choosing adult versus junior dosing. Schools must keep and make available written training materials and notify staff annually about volunteer opportunities, training, and device locations.The bill also covers liability and logistics: authorizing physicians are shielded from liability for issuing standing prescriptions unless they act with gross negligence or worse; districts must provide defense and indemnification for employees who volunteer under the statute and document that protection in personnel files; and schools may accept gifts, grants, or device donations from any source to implement the program.
Private schools may opt out after evaluating emergency response times and, if they decline, cannot receive state funds specifically for this purpose.
The Five Things You Need to Know
Quantity standard: elementary schools must have at least one regular and one junior epinephrine delivery system; middle and high schools must have at least one regular device unless pupils require junior dosing.
Restocking deadline: any device used must be replaced as soon as reasonably possible but no later than two weeks after use, and all stocked devices must be replaced before their expiration date.
Training review: the State Superintendent will review minimum training standards at least every five years and consult medical and allergy organizations; training must conform to the CDC’s Voluntary Guidelines for Managing Food Allergies in Schools.
Liability protection: authorizing physicians who issue school prescriptions are immune from civil or criminal liability except for gross negligence or willful malicious conduct; school districts must provide defense and indemnification for volunteers who administer devices.
Privates and donations: private K–12 schools may decline to participate (after assessing EMS response time) and, if they opt out, won’t receive state funds for this purpose; public schools and agencies may accept donations or device supplies from manufacturers or other sources.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Duty to stock and allow use by nurses or trained volunteers
This provision imposes the main operational duty on school districts, county offices, and charter schools to provide at least one FDA‑approved epinephrine delivery device kept in an accessible location and available to school nurses or employees who volunteer and receive training. Practically, districts must decide storage locations, inventory controls, and point‑of‑care access protocols so that devices are available during school hours and events.
Definitions that shape scope and application
The bill defines key terms—anaphylaxis, authorizing physician and surgeon, epinephrine delivery system, qualified supervisor of health, and volunteer/trained personnel—in ways that broaden who can authorize and administer care. For example, an authorizing physician can be a medical director of a local health agency or emergency medical services director, which expands potential prescribers beyond an individual student’s physician and affects how districts secure standing orders.
Private schools, volunteer selection, and training assignment
Private elementary and secondary schools may opt out of stocking devices after considering emergency medical services response time; if they decline, the statute bars them from receiving state funds specifically for this program. Both public and private schools may designate volunteers to receive initial and annual refresher training; volunteers may be employees or holders of an Activity Supervisor Clearance Certificate, and they must be chosen and trained under school oversight.
Training content, review cycle, and required materials
The Superintendent must review minimum training standards at least every five years and consult a long list of clinical and public‑health stakeholders. Training must teach symptom recognition, storage and restocking procedures, emergency follow‑up (including 911 and contacting parents/physicians), CPR recommendations, and dosing decisions (adult vs junior). Schools must retain and make the written materials available—posting them at the device location is explicitly contemplated—creating a documentation and compliance trace.
Notification, prescription rules, stocking responsibilities, and restocking timelines
Districts must notify all staff annually about the volunteer recruitment, the training content, and device locations. A qualified supervisor of health must obtain a prescription or standing order for each school; the prescription model specifies device counts by school level and assigns responsibility for stocking and restocking to that supervisor or, if absent, an administrator. The law allows filling prescriptions through local or mail‑order pharmacies or manufacturers and requires devices used to be replaced within two weeks and replenished before expiration.
Post‑use procedures, indemnification, and donations
Volunteers must initiate emergency medical services and other follow‑up aligned with training after using a device. The district must provide written defense and indemnification to volunteers for civil liability and retain that documentation in personnel files. Public schools and agencies may accept gifts, grants, or donations—including direct device donations from manufacturers—introducing a regulated but potentially close relationship between districts and suppliers.
This bill is one of many.
Codify tracks hundreds of bills on Education across all five countries.
Explore Education in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Students at risk of anaphylaxis: faster onsite access to epinephrine reduces delay to life‑saving treatment, especially in situations where EMS response is slow.
- School nurses and trained staff: clear statutory authority and procedures for administering epinephrine reduce legal uncertainty and standardize training expectations.
- Parents and guardians of students with severe allergies: increased assurance that schools carry backup emergency medication and documented protocols for emergency follow‑up.
- Public health and emergency medical systems: standardized school protocols and training materials improve coordination between schools and 911 services when anaphylaxis occurs.
Who Bears the Cost
- School districts, county offices, and charter schools: procurement, inventory management, training delivery, recordkeeping, and restocking (including replacing expired devices) create recurring budget and administrative burdens.
- Volunteers and employees: time demands for initial and annual refresher training and potential additional duties tied to storage, inspection, or documentation.
- Small private schools that choose to participate: while optional, those that opt in must absorb the same operational and procurement costs without eligibility for targeted state funding.
- Local administrators and qualified supervisors of health: responsibility for prescriptions, keeping inventory, and ensuring timely restocking increases operational workload for site leaders.
Key Issues
The Core Tension
The bill pits the public‑health imperative of ensuring immediate access to life‑saving epinephrine against the fiscal, logistical, and oversight burdens placed on local schools: faster access improves safety but requires recurring spending, inventory discipline, and clear training and liability frameworks that the statute leaves largely to local administrators to operationalize.
The bill ties an important emergency capability to specific operational obligations without creating a dedicated funding stream, so implementation will shift costs onto local education agencies. Devices have limited shelf lives and per‑unit cost variability; the two‑week replacement mandate after use can strain small district budgets or require standing purchase agreements with suppliers.
Allowing prescriptions to be filled directly by manufacturers or via mail order helps procurement flexibility but raises logistics questions about storage, immediate access, and cold‑chain or delivery timing when used devices must be replaced quickly.
Liability language favors access—authorizing physicians and volunteers receive strong protections—but those shields rest on vague standards like gross negligence for carve‑outs. That reduces legal fear for prescribers and volunteers but also reduces the deterrent against sloppy delegation, poor training, or lax inventory controls.
Permitting donations from manufacturers solves short‑term supply problems but opens potential conflict‑of‑interest issues and requires transparent district policies to avoid perception (or reality) of undue influence over product choice or stocking practices.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.